Industry News

Emerging Technologies Guide: November 2024

Recent new and emerging technologies in the field of laboratory medicine from the 2024 November Genetics & Genomics issue of Today's Clinical Lab

Written byToday's Clinical Lab
| 2 min read
Hamilton's innovative Verso Dx is an automated postanalytical storage system that caters to different workflows thanks to its ability to load samples either manually or via lab track.
Register for free to listen to this article
Listen with Speechify
0:00
2:00


Image of the INTEGRA Biosciences MAG and HEATMAG modules.


INTEGRA Biosciences is excited to announce the launch of its MAG and HEATMAG modules for efficient, automated magnetic bead purification. These innovative solutions allow researchers to streamline several processing steps in molecular biology and proteomics workflows for maximum lab throughput. These time-saving devices are complemented by the COLDPLATE and BIOSHAKE—for precise temperature control and orbital shaking of magnetic beads, respectively—to further streamline protocols.

LEARN MORE


          Hamilton



Hamilton's innovative Verso Dx is an automated postanalytical storage system that caters to different workflows thanks to its ability to load samples either manually or via lab track. This flexible system, which can be built in multiple sizes, features a storage capacity ranging from 30,000 to 1 million tubes. The platform can store tubes at ambient or the common temperature of 5°C, while also boasting the capability to store samples at -20°C for special applications.



Streamline Your Clinical PCR Workflows with QIAcuityDx

      Streamline Your Clinical PCR Workflows with QIAcuityDx



QIAcuityDx is tailored for IVD applications. This fully automated digital PCR system enhances diagnostic precision and operational efficiency by reducing hands-on time and ensuring accurate detection and quantification of important genetic variations. Easily develop your own assay menu* by using QIAcuityDx utility mode and IVD medical device consumables, reagents, and software.

*FDA ‘Medical Devices; Laboratory Developed Tests’ final rule, May 6, 2024 and European Union regulation requirements on ‘In-House Assays’ (Regulation (EU) 2017/746 -IVDR- Art. 5(5)) The QIAcuityDx dPCR System is intended for in vitro diagnostic use, using automated multiplex quantification dPCR technology, for the purpose of providing diagnostic information concerning pathological states. QIAcuity and QIAcuityDx dPCR instruments are sold under license from Bio-Rad Laboratories, Inc. and exclude rights for use with pediatric applications.

Add Today's Clinical Lab as a preferred source on Google

Add Today's Clinical Lab as a preferred Google source to see more of our trusted coverage.

Related Topics

Loading Next Article...
Loading Next Article...